• Charles O.N. Wambebe, National Institute of Pharmaceutical Research and Development, Idu-Abuja, Nigeria, for his significant contributions to the understanding of the role of endogenous monoamines and neuropeptides in sleep mechanism, seizures, temperature regulation, anxiety and seizure disorders and in particular for the development of drugs from local plants for the treatment of sickle cell anaemia, peptic ulcer, tropical skin infection and diabetes
Charles Wambebe, pharmacist and administrator, 65, September 8.Born in Kogi State, he was educated at Government Secondary School, Okene, 1962-1966; Obafemi Awolowo University, OAU, Ile-Ife, 1972; Ahmadu Bello University, Zaria, 1979.He became assistant lecturer, 1973-1975; appointed associate professor, ABU-Zaria, 1983-1988; professor of pharmacy, ABU, Zaria, 1988; appointed director, National Institute for Pharmaceutical Research and Development, Abuja, 1988; appointed director-general /chief executive officer, National Institute for Pharmaceutical Research and Development, NIPRD, 1999.
Wambebe isa member of Society of Biological Psychiatry; member, Academy of Phamacology; member, Academy of Pharmaceutical Sciences.
Director General of NIPRD), Dr. Charles Wambebe, at the WHO Forum on Traditional Medicine in Health Systems, Zimbabwe, Harare, February 14-18, 2000, gave a fascinating presentation about the development of two phytomedicines.
Wambebe said: "But since research results will no doubt be published, I will confine my comments to the NIPRD's plan for recognising the intellectual property rights of traditional healers by means of a scheme for sharing any future royalties from a phytomedicine that becomes a profitable drug (or patentable comound).
CHIEF SCIENTIFIC ADVISORProf. Wambebe is the Founder and Chief Scientific Advisor of IBRI.Prior to this position, he was a Short Term Professional with the World Health Organization ReGional Office for Africa, Brazzaville, Congo.At the WHO, Prof Wambebe assisted the Traditional Medicine Program with development of clinical protocols and providing technical guidance to the Member States of the WHO African region.Prof Wambebe also represented the WHO on the Partnership Board of the European and Developing Countries Clinical Trials Partnership (EDCTP) and served as a member of the EDCTP-WHO Liaison Group.Previously, Prof Wambebe was the pioneer Director General and Chief Executive Officer of NIPRD.During his tenure at the institute, eleven herbal medicines were developed from indigenous plants for the treatment of sickle cell anemia, malaria, HIV/AIDS, peptic ulcer, skin fungal infection, oral contraception and cough.These herbal medicines are currently in various indicated stages of clinical trials.Another accomplishment while at the institute includes extensive ethno-botanical surveys and scientific documentation of over 600 hundred medicinal plants indigenous to Nigerian, in the Nigerian Herbal Pharmacopoeia.Prof. Wambebe has received numerous scientific achievement and leadership awards and serves in various capacities as a Fellow of the Third World Academy of Science, WHO Expert Panel on Traditional Medicine, a member of an African Task Force on HIV/AIDS Disease and the Editor-in-Chief of Phytomedicine and Therapeutics Journal among many other roles.He has published over 100 articles in neuropharmacology, ethnopharmacology and clinical medicine.His key research findings include the role of endogenous monoamines in sleep mechanisms, etiology of seizures and temperature regulation, involvement of indigenous endogenous family of neuropeptides derived from diazepam binding inhibitor in anxiety disorders.Prof. Wambebe co-founded IBRIA in 2001 as a major commitment to building African capacity for clinical trials and for traditional medicinal product development. >> Read more ...
The Director General of Nigerian Institute of Pharmaceutical Research and Development (NIPRD) Prof. Charles Wambebe, also expressed satisfaction with the conduct of the public hearing.
His representative at the hearing attributed previous disagreements between HIV/AIDS claimants and government institutions in the past to fears of being shortchanged on the side of the claimants and distrusts by the public health officials. Although no financial benefit were guaranteed the claimants, they were however, all willing to cooperate with the legislators.
Thank You for Downloading!
1. Download ZoomInfo Grow
2. Run Installation Wizard
3. Check your inbox to Sign in to ZoomInfo Grow